News
(AOF) - Merck a annoncé que son produit anticancéreux Ifinatamab deruxtecan a obtenu la désignation de thérapie innovante par la Food & ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback